Monopar Therapeutics director reports stock transactions
Monopar Therapeutics director Christopher M. Starr reports significant stock transactions, reflecting confidence in the pharmaceutical company's future.
Insulet Corp CFO Pease Flavia Sells 1,882 Shares of Stock
Pease Flavia, EVP and CFO of Insulet Corp, sells 1,882 shares of common stock in a recent SEC filing, showcasing ongoing stock activity.
SI-BONE’s Jeffrey W. Dunn Executes Major Stock Transactions
SI-BONE, Inc. reports stock transactions by Jeffrey W. Dunn, highlighting active management involvement and confidence in the company's future.
Simon Barry J. sells 25,000 shares of ImmunityBio, Inc.
Simon Barry J. sold 25,000 shares of ImmunityBio, Inc. on October 5, 2026, as part of a trading plan, reducing his holdings in the company.
Patricia Hubbard Acquires Restricted Stock Units from Hexcel Corp
Patricia Hubbard reported acquiring 287 restricted stock units from Hexcel Corp, reflecting ongoing trends in corporate governance in the industry.
Riskified CFO Aglika Dotcheva Acquires 60,487 Shares
Aglika Dotcheva, CFO of Riskified Ltd., acquires over 60,000 shares in a recent stock transaction, signaling confidence in the company's future.
Jodi Taylor acquires 1,466 deferred stock units at J M Smucker
Jodi Taylor, director at J M Smucker Co, acquires 1,466 deferred stock units, signaling confidence in the company's future and the canned goods market.
Li David H reports stock transactions in Hexcel Corp
David H. Li reported stock transactions, acquiring shares and disposing of restricted stock units. Insights into Hexcel Corp's insider activities.
Robert Spence acquires shares as director of Comstock Inc.
Robert Spence acquires 9,094 shares of Comstock Inc. as part of his director compensation, reflecting the company's equity incentive strategy.
Cheryl Cohen Disposes of Shares in ImmunityBio, Inc.
Cheryl Cohen's SEC filing shows significant stock transactions in ImmunityBio, impacting investor perceptions and the biological products sector.
Riskified CEO Gal Eido Reports Share Transaction
Gal Eido, CEO of Riskified Ltd., reported a share transaction involving 34,391 Class A ordinary shares, indicating confidence in the company's stock.
Lynch acquires shares in Bank of N.T. Butterfield & Son Ltd
Mark T. Lynch, director of Bank of N.T. Butterfield & Son Ltd, acquires 1,178 shares, signaling confidence in the bank's future.
Star Equity CEO Eberwein Sells 3,000 Shares of Preferred Stock
Jeffrey Eberwein, CEO of Star Equity Holdings, reports the sale of 3,000 shares of Series A Preferred Stock, indicating a strategic trading plan.
Pittman Scott M. Reports New Warrants for Nuo Therapeutics
Scott M. Pittman files new warrants for Nuo Therapeutics, indicating potential growth in the surgical and medical instruments sector.
Pierce Ingrid Acquires Additional Shares in Butterfield Bank
Pierce Ingrid increases her stake in Bank of N.T. Butterfield & Son Ltd by acquiring 1,178 shares, totaling 7,717 shares owned.
Phyllis Gotlib Sells Shares to Cover Tax Liability
Phyllis Gotlib of American Well Corp sells shares for tax liabilities, reflecting financial management in the business services sector.
Kite Realty Group Trust Director Reports Share Transaction
Kite Realty Group Trust director Victor J. Coleman reports acquisition of 486 shares, reflecting ongoing activity in the real estate investment trust sector.
Goldberg Michael reports stock transaction for CareDx, Inc.
Goldberg Michael discloses a transaction of 588 shares in CareDx, Inc. as part of director compensation, reflecting ongoing practices in the medical laboratories sector.
Elanco CEO Simmons Acquires Deferred Stock Units
Elanco's CEO, Jeffrey N. Simmons, acquires deferred stock units, reflecting the company's focus on performance-based compensation amid industry competition.
David C. Habiger Reports Stock Transactions with EnerSys
David C. Habiger reports multiple stock transactions with EnerSys, emphasizing executive compensation management and shareholder alignment.